Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Insomnia Treatment Drugs Market Growth (Status and Outlook) 2022-2028

  • LP 4802324
  • 102 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Insomnia Treatment Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Insomnia Treatment Drugs market size is USD million in 2022 from USD 2858.1 million in 2021, with a change of % between 2021 and 2022. The global Insomnia Treatment Drugs market size will reach USD 3645.5 million in 2028, growing at a CAGR of 3.5% over the analysis period.

The United States Insomnia Treatment Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Insomnia Treatment Drugs market, reaching US$ million by the year 2028. As for the Europe Insomnia Treatment Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Insomnia Treatment Drugs players cover F.Hoffman La-Roche AG, Merck & Co. Inc., Mylan N.V., and Pfizer, Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Insomnia Treatment Drugs market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Prescription Sleep Aids

Over the Counter (OTC) Sleep Aids

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Hospital

Pharmacy

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

F.Hoffman La-Roche AG

Merck & Co. Inc.

Mylan N.V.

Pfizer, Inc.

Pernix Therapeutics

Sanofi S.A.

Takeda Pharmaceutical Company Ltd.

Sumitomo Dainippon Pharma Co., Ltd

Teva Pharmaceutical Industries Ltd.

Vanda Pharmaceuticals, Inc.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Insomnia Treatment Drugs Market Size 2017-2028

2.1.2 Insomnia Treatment Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Insomnia Treatment Drugs Segment by Type

2.2.1 Prescription Sleep Aids

2.2.2 Over the Counter (OTC) Sleep Aids

2.3 Insomnia Treatment Drugs Market Size by Type

2.3.1 Insomnia Treatment Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Insomnia Treatment Drugs Market Size Market Share by Type (2017-2022)

2.4 Insomnia Treatment Drugs Segment by Application

2.4.1 Hospital

2.4.2 Pharmacy

2.4.3 Others

2.5 Insomnia Treatment Drugs Market Size by Application

2.5.1 Insomnia Treatment Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Insomnia Treatment Drugs Market Size Market Share by Application (2017-2022)

3 Insomnia Treatment Drugs Market Size by Player

3.1 Insomnia Treatment Drugs Market Size Market Share by Players

3.1.1 Global Insomnia Treatment Drugs Revenue by Players (2020-2022)

3.1.2 Global Insomnia Treatment Drugs Revenue Market Share by Players (2020-2022)

3.2 Global Insomnia Treatment Drugs Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Insomnia Treatment Drugs by Regions

4.1 Insomnia Treatment Drugs Market Size by Regions (2017-2022)

4.2 Americas Insomnia Treatment Drugs Market Size Growth (2017-2022)

4.3 APAC Insomnia Treatment Drugs Market Size Growth (2017-2022)

4.4 Europe Insomnia Treatment Drugs Market Size Growth (2017-2022)

4.5 Middle East & Africa Insomnia Treatment Drugs Market Size Growth (2017-2022)

5 Americas

5.1 Americas Insomnia Treatment Drugs Market Size by Country (2017-2022)

5.2 Americas Insomnia Treatment Drugs Market Size by Type (2017-2022)

5.3 Americas Insomnia Treatment Drugs Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Insomnia Treatment Drugs Market Size by Region (2017-2022)

6.2 APAC Insomnia Treatment Drugs Market Size by Type (2017-2022)

6.3 APAC Insomnia Treatment Drugs Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Insomnia Treatment Drugs by Country (2017-2022)

7.2 Europe Insomnia Treatment Drugs Market Size by Type (2017-2022)

7.3 Europe Insomnia Treatment Drugs Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Insomnia Treatment Drugs by Region (2017-2022)

8.2 Middle East & Africa Insomnia Treatment Drugs Market Size by Type (2017-2022)

8.3 Middle East & Africa Insomnia Treatment Drugs Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Insomnia Treatment Drugs Market Forecast

10.1 Global Insomnia Treatment Drugs Forecast by Regions (2023-2028)

10.1.1 Global Insomnia Treatment Drugs Forecast by Regions (2023-2028)

10.1.2 Americas Insomnia Treatment Drugs Forecast

10.1.3 APAC Insomnia Treatment Drugs Forecast

10.1.4 Europe Insomnia Treatment Drugs Forecast

10.1.5 Middle East & Africa Insomnia Treatment Drugs Forecast

10.2 Americas Insomnia Treatment Drugs Forecast by Country (2023-2028)

10.2.1 United States Insomnia Treatment Drugs Market Forecast

10.2.2 Canada Insomnia Treatment Drugs Market Forecast

10.2.3 Mexico Insomnia Treatment Drugs Market Forecast

10.2.4 Brazil Insomnia Treatment Drugs Market Forecast

10.3 APAC Insomnia Treatment Drugs Forecast by Region (2023-2028)

10.3.1 China Insomnia Treatment Drugs Market Forecast

10.3.2 Japan Insomnia Treatment Drugs Market Forecast

10.3.3 Korea Insomnia Treatment Drugs Market Forecast

10.3.4 Southeast Asia Insomnia Treatment Drugs Market Forecast

10.3.5 India Insomnia Treatment Drugs Market Forecast

10.3.6 Australia Insomnia Treatment Drugs Market Forecast

10.4 Europe Insomnia Treatment Drugs Forecast by Country (2023-2028)

10.4.1 Germany Insomnia Treatment Drugs Market Forecast

10.4.2 France Insomnia Treatment Drugs Market Forecast

10.4.3 UK Insomnia Treatment Drugs Market Forecast

10.4.4 Italy Insomnia Treatment Drugs Market Forecast

10.4.5 Russia Insomnia Treatment Drugs Market Forecast

10.5 Middle East & Africa Insomnia Treatment Drugs Forecast by Region (2023-2028)

10.5.1 Egypt Insomnia Treatment Drugs Market Forecast

10.5.2 South Africa Insomnia Treatment Drugs Market Forecast

10.5.3 Israel Insomnia Treatment Drugs Market Forecast

10.5.4 Turkey Insomnia Treatment Drugs Market Forecast

10.5.5 GCC Countries Insomnia Treatment Drugs Market Forecast

10.6 Global Insomnia Treatment Drugs Forecast by Type (2023-2028)

10.7 Global Insomnia Treatment Drugs Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 F.Hoffman La-Roche AG

11.1.1 F.Hoffman La-Roche AG Company Information

11.1.2 F.Hoffman La-Roche AG Insomnia Treatment Drugs Product Offered

11.1.3 F.Hoffman La-Roche AG Insomnia Treatment Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 F.Hoffman La-Roche AG Main Business Overview

11.1.5 F.Hoffman La-Roche AG Latest Developments

11.2 Merck & Co. Inc.

11.2.1 Merck & Co. Inc. Company Information

11.2.2 Merck & Co. Inc. Insomnia Treatment Drugs Product Offered

11.2.3 Merck & Co. Inc. Insomnia Treatment Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Merck & Co. Inc. Main Business Overview

11.2.5 Merck & Co. Inc. Latest Developments

11.3 Mylan N.V.

11.3.1 Mylan N.V. Company Information

11.3.2 Mylan N.V. Insomnia Treatment Drugs Product Offered

11.3.3 Mylan N.V. Insomnia Treatment Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Mylan N.V. Main Business Overview

11.3.5 Mylan N.V. Latest Developments

11.4 Pfizer, Inc.

11.4.1 Pfizer, Inc. Company Information

11.4.2 Pfizer, Inc. Insomnia Treatment Drugs Product Offered

11.4.3 Pfizer, Inc. Insomnia Treatment Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Pfizer, Inc. Main Business Overview

11.4.5 Pfizer, Inc. Latest Developments

11.5 Pernix Therapeutics

11.5.1 Pernix Therapeutics Company Information

11.5.2 Pernix Therapeutics Insomnia Treatment Drugs Product Offered

11.5.3 Pernix Therapeutics Insomnia Treatment Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Pernix Therapeutics Main Business Overview

11.5.5 Pernix Therapeutics Latest Developments

11.6 Sanofi S.A.

11.6.1 Sanofi S.A. Company Information

11.6.2 Sanofi S.A. Insomnia Treatment Drugs Product Offered

11.6.3 Sanofi S.A. Insomnia Treatment Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Sanofi S.A. Main Business Overview

11.6.5 Sanofi S.A. Latest Developments

11.7 Takeda Pharmaceutical Company Ltd.

11.7.1 Takeda Pharmaceutical Company Ltd. Company Information

11.7.2 Takeda Pharmaceutical Company Ltd. Insomnia Treatment Drugs Product Offered

11.7.3 Takeda Pharmaceutical Company Ltd. Insomnia Treatment Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Takeda Pharmaceutical Company Ltd. Main Business Overview

11.7.5 Takeda Pharmaceutical Company Ltd. Latest Developments

11.8 Sumitomo Dainippon Pharma Co., Ltd

11.8.1 Sumitomo Dainippon Pharma Co., Ltd Company Information

11.8.2 Sumitomo Dainippon Pharma Co., Ltd Insomnia Treatment Drugs Product Offered

11.8.3 Sumitomo Dainippon Pharma Co., Ltd Insomnia Treatment Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Sumitomo Dainippon Pharma Co., Ltd Main Business Overview

11.8.5 Sumitomo Dainippon Pharma Co., Ltd Latest Developments

11.9 Teva Pharmaceutical Industries Ltd.

11.9.1 Teva Pharmaceutical Industries Ltd. Company Information

11.9.2 Teva Pharmaceutical Industries Ltd. Insomnia Treatment Drugs Product Offered

11.9.3 Teva Pharmaceutical Industries Ltd. Insomnia Treatment Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Teva Pharmaceutical Industries Ltd. Main Business Overview

11.9.5 Teva Pharmaceutical Industries Ltd. Latest Developments

11.10 Vanda Pharmaceuticals, Inc.

11.10.1 Vanda Pharmaceuticals, Inc. Company Information

11.10.2 Vanda Pharmaceuticals, Inc. Insomnia Treatment Drugs Product Offered

11.10.3 Vanda Pharmaceuticals, Inc. Insomnia Treatment Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Vanda Pharmaceuticals, Inc. Main Business Overview

11.10.5 Vanda Pharmaceuticals, Inc. Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Insomnia Treatment Drugs Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Prescription Sleep Aids

Table 3. Major Players of Over the Counter (OTC) Sleep Aids

Table 4. Insomnia Treatment Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Insomnia Treatment Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Insomnia Treatment Drugs Market Size Market Share by Type (2017-2022)

Table 7. Insomnia Treatment Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Insomnia Treatment Drugs Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Insomnia Treatment Drugs Market Size Market Share by Application (2017-2022)

Table 10. Global Insomnia Treatment Drugs Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Insomnia Treatment Drugs Revenue Market Share by Player (2020-2022)

Table 12. Insomnia Treatment Drugs Key Players Head office and Products Offered

Table 13. Insomnia Treatment Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Insomnia Treatment Drugs Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Insomnia Treatment Drugs Market Size Market Share by Regions (2017-2022)

Table 18. Americas Insomnia Treatment Drugs Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Insomnia Treatment Drugs Market Size Market Share by Country (2017-2022)

Table 20. Americas Insomnia Treatment Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Insomnia Treatment Drugs Market Size Market Share by Type (2017-2022)

Table 22. Americas Insomnia Treatment Drugs Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Insomnia Treatment Drugs Market Size Market Share by Application (2017-2022)

Table 24. APAC Insomnia Treatment Drugs Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Insomnia Treatment Drugs Market Size Market Share by Region (2017-2022)

Table 26. APAC Insomnia Treatment Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Insomnia Treatment Drugs Market Size Market Share by Type (2017-2022)

Table 28. APAC Insomnia Treatment Drugs Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Insomnia Treatment Drugs Market Size Market Share by Application (2017-2022)

Table 30. Europe Insomnia Treatment Drugs Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Insomnia Treatment Drugs Market Size Market Share by Country (2017-2022)

Table 32. Europe Insomnia Treatment Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Insomnia Treatment Drugs Market Size Market Share by Type (2017-2022)

Table 34. Europe Insomnia Treatment Drugs Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Insomnia Treatment Drugs Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Insomnia Treatment Drugs Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Insomnia Treatment Drugs Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Insomnia Treatment Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Insomnia Treatment Drugs Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Insomnia Treatment Drugs Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Insomnia Treatment Drugs Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Insomnia Treatment Drugs

Table 43. Key Market Challenges & Risks of Insomnia Treatment Drugs

Table 44. Key Industry Trends of Insomnia Treatment Drugs

Table 45. Global Insomnia Treatment Drugs Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Insomnia Treatment Drugs Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Insomnia Treatment Drugs Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Insomnia Treatment Drugs Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Insomnia Treatment Drugs Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Insomnia Treatment Drugs Market Size Market Share Forecast by Application (2023-2028)

Table 51. F.Hoffman La-Roche AG Details, Company Type, Insomnia Treatment Drugs Area Served and Its Competitors

Table 52. F.Hoffman La-Roche AG Insomnia Treatment Drugs Product Offered

Table 53. F.Hoffman La-Roche AG Insomnia Treatment Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. F.Hoffman La-Roche AG Main Business

Table 55. F.Hoffman La-Roche AG Latest Developments

Table 56. Merck & Co. Inc. Details, Company Type, Insomnia Treatment Drugs Area Served and Its Competitors

Table 57. Merck & Co. Inc. Insomnia Treatment Drugs Product Offered

Table 58. Merck & Co. Inc. Main Business

Table 59. Merck & Co. Inc. Insomnia Treatment Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Merck & Co. Inc. Latest Developments

Table 61. Mylan N.V. Details, Company Type, Insomnia Treatment Drugs Area Served and Its Competitors

Table 62. Mylan N.V. Insomnia Treatment Drugs Product Offered

Table 63. Mylan N.V. Main Business

Table 64. Mylan N.V. Insomnia Treatment Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Mylan N.V. Latest Developments

Table 66. Pfizer, Inc. Details, Company Type, Insomnia Treatment Drugs Area Served and Its Competitors

Table 67. Pfizer, Inc. Insomnia Treatment Drugs Product Offered

Table 68. Pfizer, Inc. Main Business

Table 69. Pfizer, Inc. Insomnia Treatment Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Pfizer, Inc. Latest Developments

Table 71. Pernix Therapeutics Details, Company Type, Insomnia Treatment Drugs Area Served and Its Competitors

Table 72. Pernix Therapeutics Insomnia Treatment Drugs Product Offered

Table 73. Pernix Therapeutics Main Business

Table 74. Pernix Therapeutics Insomnia Treatment Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Pernix Therapeutics Latest Developments

Table 76. Sanofi S.A. Details, Company Type, Insomnia Treatment Drugs Area Served and Its Competitors

Table 77. Sanofi S.A. Insomnia Treatment Drugs Product Offered

Table 78. Sanofi S.A. Main Business

Table 79. Sanofi S.A. Insomnia Treatment Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Sanofi S.A. Latest Developments

Table 81. Takeda Pharmaceutical Company Ltd. Details, Company Type, Insomnia Treatment Drugs Area Served and Its Competitors

Table 82. Takeda Pharmaceutical Company Ltd. Insomnia Treatment Drugs Product Offered

Table 83. Takeda Pharmaceutical Company Ltd. Main Business

Table 84. Takeda Pharmaceutical Company Ltd. Insomnia Treatment Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Takeda Pharmaceutical Company Ltd. Latest Developments

Table 86. Sumitomo Dainippon Pharma Co., Ltd Details, Company Type, Insomnia Treatment Drugs Area Served and Its Competitors

Table 87. Sumitomo Dainippon Pharma Co., Ltd Insomnia Treatment Drugs Product Offered

Table 88. Sumitomo Dainippon Pharma Co., Ltd Main Business

Table 89. Sumitomo Dainippon Pharma Co., Ltd Insomnia Treatment Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. Sumitomo Dainippon Pharma Co., Ltd Latest Developments

Table 91. Teva Pharmaceutical Industries Ltd. Details, Company Type, Insomnia Treatment Drugs Area Served and Its Competitors

Table 92. Teva Pharmaceutical Industries Ltd. Insomnia Treatment Drugs Product Offered

Table 93. Teva Pharmaceutical Industries Ltd. Main Business

Table 94. Teva Pharmaceutical Industries Ltd. Insomnia Treatment Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. Teva Pharmaceutical Industries Ltd. Latest Developments

Table 96. Vanda Pharmaceuticals, Inc. Details, Company Type, Insomnia Treatment Drugs Area Served and Its Competitors

Table 97. Vanda Pharmaceuticals, Inc. Insomnia Treatment Drugs Product Offered

Table 98. Vanda Pharmaceuticals, Inc. Main Business

Table 99. Vanda Pharmaceuticals, Inc. Insomnia Treatment Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. Vanda Pharmaceuticals, Inc. Latest Developments

List of Figures

Figure 1. Insomnia Treatment Drugs Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Insomnia Treatment Drugs Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Insomnia Treatment Drugs Market Size Market Share by Type in 2021

Figure 7. Insomnia Treatment Drugs in Hospital

Figure 8. Global Insomnia Treatment Drugs Market: Hospital (2017-2022) & ($ Millions)

Figure 9. Insomnia Treatment Drugs in Pharmacy

Figure 10. Global Insomnia Treatment Drugs Market: Pharmacy (2017-2022) & ($ Millions)

Figure 11. Insomnia Treatment Drugs in Others

Figure 12. Global Insomnia Treatment Drugs Market: Others (2017-2022) & ($ Millions)

Figure 13. Global Insomnia Treatment Drugs Market Size Market Share by Application in 2021

Figure 14. Global Insomnia Treatment Drugs Revenue Market Share by Player in 2021

Figure 15. Global Insomnia Treatment Drugs Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Insomnia Treatment Drugs Market Size 2017-2022 ($ Millions)

Figure 17. APAC Insomnia Treatment Drugs Market Size 2017-2022 ($ Millions)

Figure 18. Europe Insomnia Treatment Drugs Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Insomnia Treatment Drugs Market Size 2017-2022 ($ Millions)

Figure 20. Americas Insomnia Treatment Drugs Value Market Share by Country in 2021

Figure 21. Americas Insomnia Treatment Drugs Consumption Market Share by Type in 2021

Figure 22. Americas Insomnia Treatment Drugs Market Size Market Share by Application in 2021

Figure 23. United States Insomnia Treatment Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Insomnia Treatment Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Insomnia Treatment Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Insomnia Treatment Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Insomnia Treatment Drugs Market Size Market Share by Region in 2021

Figure 28. APAC Insomnia Treatment Drugs Market Size Market Share by Application in 2021

Figure 29. China Insomnia Treatment Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Insomnia Treatment Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Insomnia Treatment Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Insomnia Treatment Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Insomnia Treatment Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Insomnia Treatment Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Insomnia Treatment Drugs Market Size Market Share by Country in 2021

Figure 36. Europe Insomnia Treatment Drugs Market Size Market Share by Type in 2021

Figure 37. Europe Insomnia Treatment Drugs Market Size Market Share by Application in 2021

Figure 38. Germany Insomnia Treatment Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Insomnia Treatment Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Insomnia Treatment Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Insomnia Treatment Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Insomnia Treatment Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Insomnia Treatment Drugs Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Insomnia Treatment Drugs Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Insomnia Treatment Drugs Market Size Market Share by Application in 2021

Figure 46. Egypt Insomnia Treatment Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Insomnia Treatment Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Insomnia Treatment Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Insomnia Treatment Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Insomnia Treatment Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Insomnia Treatment Drugs Market Size 2023-2028 ($ Millions)

Figure 52. APAC Insomnia Treatment Drugs Market Size 2023-2028 ($ Millions)

Figure 53. Europe Insomnia Treatment Drugs Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Insomnia Treatment Drugs Market Size 2023-2028 ($ Millions)

Figure 55. United States Insomnia Treatment Drugs Market Size 2023-2028 ($ Millions)

Figure 56. Canada Insomnia Treatment Drugs Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Insomnia Treatment Drugs Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Insomnia Treatment Drugs Market Size 2023-2028 ($ Millions)

Figure 59. China Insomnia Treatment Drugs Market Size 2023-2028 ($ Millions)

Figure 60. Japan Insomnia Treatment Drugs Market Size 2023-2028 ($ Millions)

Figure 61. Korea Insomnia Treatment Drugs Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Insomnia Treatment Drugs Market Size 2023-2028 ($ Millions)

Figure 63. India Insomnia Treatment Drugs Market Size 2023-2028 ($ Millions)

Figure 64. Australia Insomnia Treatment Drugs Market Size 2023-2028 ($ Millions)

Figure 65. Germany Insomnia Treatment Drugs Market Size 2023-2028 ($ Millions)

Figure 66. France Insomnia Treatment Drugs Market Size 2023-2028 ($ Millions)

Figure 67. UK Insomnia Treatment Drugs Market Size 2023-2028 ($ Millions)

Figure 68. Italy Insomnia Treatment Drugs Market Size 2023-2028 ($ Millions)

Figure 69. Russia Insomnia Treatment Drugs Market Size 2023-2028 ($ Millions)

Figure 70. Spain Insomnia Treatment Drugs Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Insomnia Treatment Drugs Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Insomnia Treatment Drugs Market Size 2023-2028 ($ Millions)

Figure 73. Israel Insomnia Treatment Drugs Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Insomnia Treatment Drugs Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Insomnia Treatment Drugs Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390